ストックスクリーナーアプリを入手
2.4363
0.15%
-0.0037
前日終値:
$2.44
開ける：
$2.44
24時間の取引高:
29,668
Relative Volume:
0.01
時価総額：
$3.24M
収益：
$9.81M
当期純損益:
$-26.16M
株価収益率:
-0.0628
EPS:
-38.77
ネットキャッシュフロー:
$-17.45M
1週間 パフォーマンス:
-1.76%
1か月 パフォーマンス:
+0.26%
6か月 パフォーマンス:
-97.42%
1年 パフォーマンス:
-99.12%
1日の値動き範囲:
$2.35
$2.44
1週間の範囲:
$2.31
$2.56
52週間の値動き範囲:
$2.23
$303.25
Reshape Lifesciences Inc Stock (RSLS) Company Profile
名前
Reshape Lifesciences Inc
セクター
電話
949-429-6680
住所
1001 CALLE AMANECER, SAN CLEMENTE
RSLS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RSLS
Reshape Lifesciences Inc
|
2.4363 | 6.04M | 9.81M | -26.16M | -17.45M | -38.77 |
|
ABT
Abbott Laboratories
|
126.55 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.84 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
378.81 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.92 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.11 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Reshape Lifesciences Inc (RSLS) 最新ニュース
What is the dividend policy of ReShape Lifesciences Inc. stockPost Market Trend Scanner For Smart Trading - jammulinksnews.com
What are ReShape Lifesciences Inc. company’s key revenue driversFree Stock Review Backed By Experts - jammulinksnews.com
Is ReShape Lifesciences Inc. a growth stock or a value stockExpert Picks Review With Low Risk - jammulinksnews.com
Why ReShape Lifesciences Inc. stock attracts strong analyst attentionLow Risk Picks for Daily Trading Released - beatles.ru
ReShape Lifesciences Inc. Pullback Analyzed — Is It Time to ExitAI Forecast for Trending Stocks Indicates Upside - metal.it
ReShape Lifesciences Inc. Forms Double Bottom Pattern — Eyes on BreakoutWatchlist for Smart Swing Trading Updated - metal.it
Published on: 2025-07-29 19:35:19 - metal.it
Options Data Show Bullish Bias in ReShape Lifesciences Inc.Pattern Alert With ROI Driven Strategy Shared - metal.it
ReShape Lifesciences Inc. Inches Toward Key Resistance — Will It BreakReal Trader Watchlist of Hot Stocks Released - metal.it
What are analysts’ price targets for ReShape Lifesciences Inc. in the next 12 monthsTrack high-yield stocks before they peak - jammulinksnews.com
What are the latest earnings results for ReShape Lifesciences Inc.Achieve breakthrough profits with smart strategies - jammulinksnews.com
How strong is ReShape Lifesciences Inc. company’s balance sheetUnprecedented profits - jammulinksnews.com
How does ReShape Lifesciences Inc. generate profit in a changing economyAchieve impressive returns with smart timing - jammulinksnews.com
Is it the right time to buy ReShape Lifesciences Inc. stockBuild wealth faster with consistent growth stocks - jammulinksnews.com
What are the technical indicators suggesting about ReShape Lifesciences Inc.Gain insights from top financial experts - jammulinksnews.com
ReShape Lifesciences Holds Special Stockholder Meeting - TipRanks
ReShape Lifesciences Inc. Stock Analysis and ForecastFree Market Volatility Navigation Tips - Autocar Professional
What drives ReShape Lifesciences Inc. stock priceTremendous growth potential - PrintWeekIndia
What analysts say about ReShape Lifesciences Inc. stockPhenomenal capital appreciation - Autocar Professional
Will ReShape Lifesciences Inc. stock split in the near futureOverwhelming profit margins - jammulinksnews.com
ReShape Lifesciences Announces Partial Adjournment of Stockholder Meeting for Asset Sale and Charter Amendment Proposals - Nasdaq
ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders - GlobeNewswire
Rockford Register Star: Local News, Politics & Sports in Rockford, IL - FinancialContent
ReShape Lifesciences Hosts Special Meeting of Stockholders on July 24, 2025 - AInvest
Is ReShape Lifesciences Inc. a good long term investmentHigh-profit stock alerts - jammulinksnews.com
ReShape's New Lap-Band 2.0 FLEX Targets GLP-1 Era: Top Surgeons Gather for Groundbreaking Summit - Stock Titan
ReShape Lifesciences® to Host Inaugural Lap-Band® Surgeon Summit - GlobeNewswire
ReShape Lifesciences Board Unanimously Recommends Merger with Vyome Therapeutics and Sale of Assets to Biorad Medisys - Nasdaq
ReShape Lifesciences® Receives Notice of Allowance for Key U.S. Patent Related to an Intragastric Balloon System - Yahoo.co
ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025 - GlobeNewswire
ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025 - Benzinga
ReShape Lifesciences Strategic Transformation: Board and Proxy Advisors Unite Behind Vyome Merger - Stock Titan
Reshape Lifesciences Inc (RSLS) 財務データ
収益
当期純利益
現金流量
EPS
0.98%
1.34%
大文字化:
|
ボリューム (24 時間):